As of January 22, 2025, Madrigal Pharmaceuticals (MDGL) has a market cap of $6.99 billion USD. According to our data, Madrigal Pharmaceuticals is ranked No.2163 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $6.99 B |
3.91%
|
Dec 31, 2024 | $6.73 B |
33.36%
|
Dec 29, 2023 | $5.05 B |
-20.28%
|
Dec 30, 2022 | $6.33 B |
242.52%
|
Dec 31, 2021 | $1.85 B |
-23.77%
|
Dec 31, 2020 | $2.42 B |
22.02%
|
Dec 31, 2019 | $1.99 B |
-19.17%
|
Dec 31, 2018 | $2.46 B |
22.80%
|
Dec 29, 2017 | $2.00 B |
516.04%
|
Dec 30, 2016 | $0.32 B |
21.63%
|
Dec 31, 2015 | $0.27 B |
-86.79%
|
Dec 31, 2014 | $2.02 B |
-49.43%
|
Dec 31, 2013 | $4.00 B |
-41.91%
|
Dec 31, 2012 | $6.89 B |
93.15%
|
Dec 30, 2011 | $3.56 B |
-23.69%
|
Dec 31, 2010 | $4.67 B |
20.95%
|
Dec 31, 2009 | $3.86 B |
-17.32%
|
Dec 31, 2008 | $4.67 B |
-8.66%
|
Dec 31, 2007 | $5.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Viking Therapeutics
VKTX
|
$3.89 B |
0.000 M
|
USA
|
Galmed Pharmaceuticals
GLMD
|
$4.85 M |
0.000 M
|
Israel
|
Genfit
GNFT
|
$0.18 B |
-0.000 M
|
France
|
Akero Therapeutics
AKRO
|
$1.75 B |
-0.033 B
|
USA
|
89bio
ETNB
|
$0.78 B |
0.000 M
|
USA
|
Hepion Pharmaceuticals
HEPA
|
$0.89 M |
0.000 M
|
USA
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Market Cap | = | MDGL Stock Price | * | MDGL Shares Outstanding |
= | $320.62 | * | 21.81 M | |
= | $6.99 B |